(R)-(3-Amino-2-fluoropropyl) Phosphinic Acid (AZD3355), a Novel GABAB Receptor Agonist, Inhibits Transient Lower Esophageal Sphincter Relaxation through a Peripheral Mode of Action-Reference-Cited by-同舟云学术

(R)-(3-Amino-2-fluoropropyl) Phosphinic Acid (AZD3355), a Novel GABAB Receptor Agonist, Inhibits Transient Lower Esophageal Sphincter Relaxation through a Peripheral Mode of Action

Published:2009-07-31 Issue:2 Volume:331 Page:504-512
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Lehmann Anders,Antonsson Madeleine,Holmberg Ann Aurell,Blackshaw L. Ashley,Brändén Lena,Bräuner-Osborne Hans,Christiansen Bolette,Dent John,Elebring Thomas,Jacobson Britt-Marie,Jensen Jörgen,Mattsson Jan P.,Nilsson Karolina,Oja Simo S.,Page Amanda J.,Saransaari Pirjo,von Unge Sverker

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference35 articles.

1. Synthesis and Pharmacological Evaluation of Novel γ-Aminobutyric Acid Type B (GABAB) Receptor Agonists as Gastroesophageal Reflux Inhibitors

2. Molecular Structure and Physiological Functions of GABABReceptors

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review of Gastroesophageal Reflux Disease (GERD) Treatment and its Clinical Perspectives;International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN);2023-11-15

2. GABAB-Receptor Agonist-Based Immunotherapy for Type 1 Diabetes in NOD Mice;Biomedicines;2021-01-06

3. Synopsis of recent synthetic methods and biological applications of phosphinic acid derivatives;Tetrahedron;2020-06

4. Metabolic and Pharmaceutical Aspects of Fluorinated Compounds;Journal of Medicinal Chemistry;2020-03-17

5. Acid-Suppression Therapy for Gastroesophageal Reflux Disease and the Therapeutic Gap;Shackelford's Surgery of the Alimentary Tract, 2 Volume Set;2019